Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Plos Pathogens|May 28, 2021
PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infectionSean C Murphy, Gregory A Deye, B Kim Lee Sim, et al.
The Journal of Infectious Diseases|August 19, 2025
Vaccine-induced antibodies to a C-terminal Plasmodium falciparum circumsporozoite protein epitope are associated with protectionDeAnna J Friedman-Klabanoff, Travis L Jensen, Casey E Gelber, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2010
An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to LiberiaTimothy J Whitman, Philip E Coyne, Alan J Magill, et al.
The Journal of Infectious Diseases|February 8, 2024
Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria ChallengeDeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
The Journal of Infectious Diseases|August 17, 2019
Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive AdultsMatthew B Laurens, Andrea A Berry, Mark A Travassos, et al.
Plos Neglected Tropical Diseases|March 30, 2023
A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic areaDavid J Diemert, Rodrigo Correa-Oliveira, Carlo Geraldo Fraga, et al.
Trials|March 3, 2022
EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in BrazilMatthew H Collins, Gail E Potter, Matt D T Hitchings, et al.
Frontiers in Immunology|October 1, 2025
Controlled human malaria infection with NF54 and 7G8 strains elicit differential antibody responses to Plasmodium falciparum peptidesDeAnna J Friedman-Klabanoff, Travis L Jensen, Kirsten E Lyke, et al.
Annals of Internal Medicine|February 26, 2024
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2Catharine I Paules, Jing Wang, Kay M Tomashek, et al.
Nature Communications|June 18, 2024
Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptomsPatricia Ferrer, Andrea A Berry, Allison N Bucsan, et al.
Pageof 3